Literature DB >> 3090711

Diffuse interstitial lung disease in neurofibromatosis.

J L Burkhalter, J U Morano, M B McCay.   

Abstract

An association of neurofibromatosis with diffuse interstitial lung disease is thought to exist, though there have been relatively few large studies of it. The pulmonary manifestations consist of diffuse interstitial fibrosis or formation of bullae, or a combination of both. Our experience with this disease process during a ten-year period shows slightly less than a 7% incidence of diffuse interstitial lung disease in our patients with neurofibromatosis. We include a case of neurofibromatosis and diffuse lung disease that is somewhat unusual in the formation of bullae in the lower lobe, in contradistinction to its marked upper lobe predominance.

Entities:  

Mesh:

Year:  1986        PMID: 3090711     DOI: 10.1097/00007611-198608000-00007

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

3.  Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1.

Authors:  Daniela Rodrigues; Hugo Oliveira; Carina Andrade; Luísa Carvalho; Susana Guimarães; Conceição Souto Moura; Ana Paula Vaz
Journal:  Respir Med Case Rep       Date:  2018-03-17

4.  Neurofibromatosis type 1: evaluation by chest computed tomography.

Authors:  Sérgio Ferreira Alves Júnior; Klaus Loureiro Irion; Alessandro Severo Alves de Melo; Gustavo de Souza Portes Meirelles; Rosana Souza Rodrigues; Arthur Soares Souza; Bruno Hochhegger; Gláucia Zanetti; Edson Marchiori
Journal:  Radiol Bras       Date:  2021 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.